期刊
HEMATOLOGY
卷 28, 期 1, 页码 -出版社
TAYLOR & FRANCIS LTD
DOI: 10.1080/16078454.2023.2225341
关键词
MiR-361-3p; KMT2A; acute myeloid leukemia; proliferation; migration; invasion
类别
This study investigated the expressions of miR-361-3p and KMT2A in AML tissues and cell lines, and identified an advanced target for AML therapy. The results showed low expression of miR-361-3p and high expression of KMT2A. Inhibition of KMT2A prevented AML cells from proliferating, migrating, and invading. KMT2A was also confirmed as a direct target of miR-361-3p and negatively correlated with it.
Objective: The lives and safety of humans are significantly threatened by acute myeloid leukemia (AML), which is proven to be the most prevalent acute leukemia. This work is therefore intended to investigate and analyze the expressions of miR-361-3p and Histone Lysine Methyltransferase 2A (KMT2A) in tissues and cell lines of AML and identify an advanced and novel target for the therapy of AML. Methods: The qRT-PCR and western blot assays were conducted to find expressions of miR-361-3p/KMT2A in AML PB and cell lines. After then, tests using CCK-8 and EdU were run to see how KMT2A affected the growth of AML cells. Transwell migration and invasion assay was conducted to evaluate KMT2A's contribution to the migration and invasion of AML cells. ENCORI and miRWalk predicted the association between KMT2A and miR-361-3p, and the dual-luciferase reporter experiment verified it. Furthermore, rescue studies were used to ascertain how KMT2A affected the miR-361-3p-regulated AML cells' abilities to proliferate, migrate, and invade. Results: miR-361-3p was poorly expressed while KMT2A was abundantly expressed. Additionally, KMT2A downregulation prevented AML cells from proliferating. PCNA and Ki-67 protein levels fell when KMT2A was silent. Furthermore, AML cells' motility, invasion, and metastasis were inhibited by low KMT2A expression. KMT2A was also identified as a direct target of miR-361-3p and negatively correlated with miR-361-3p. Finally, the over-expression of KMT2A partially reversed the inhibitory effects of up-regulation of miR-361-3p. Conclusion: A potential therapeutic candidate target for the treatment of AML may be miR-361-3p/KMT2A.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据